glp 1 gip glucagon triple agonist Hitting the G Spot: The New Triple G for Weight Loss In the ATTAIN-1 phase 3,

I am not given up my *affiliated* PCP over this, which is why I am trying the endocrinology route

GLP-1 receptors are present in Sertoli and Leydig cells, which means that these drugs have the potential to directly affect testicular function in addition to improving hormonal balance

[DOI] [PMC free article] [PubMed] [Google Scholar] 87.Anazco D., Fansa S., Hurtado M.D., Camilleri M., Acosta A

These side effects have been primarily seen in with use of these medications over month to a few years with longer term surveillance ongoing

Blood sugar control: Up to 80% of people with PMOS have insulin resistance, which can affect both diabetes risk and pelvic floor function

Future research also could explore the effects of individual GLP-1 agents rather than the drug class as a whole